Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04542057
Recruitment Status : Active, not recruiting
First Posted : September 9, 2020
Last Update Posted : May 16, 2022
Iqvia Pty Ltd
Information provided by (Responsible Party):
Verona Pharma plc

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : May 3, 2022
Estimated Study Completion Date : July 2, 2022